Based on available data, the combined effects of Gal-3 on macrophages, lung epithelial cells and neutrophil function, suggest that the inhibition of Gal-3 may serve as a potential strategy for the treatment of ALI. The gene discussed is LGALS3; the disease is acute respiratory distress syndrome.